As of Aug 23
| +1.54 / +1.68%|
The 9 analysts offering 12-month price forecasts for China Biologic Products Holdings Inc have a median target of 128.00, with a high estimate of 135.00 and a low estimate of 106.10. The median estimate represents a +37.34% increase from the last price of 93.20.
The current consensus among 9 polled investment analysts is to Buy stock in China Biologic Products Holdings Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.